NAVARINI, LUCA
 Distribuzione geografica
Continente #
AS - Asia 5.946
NA - Nord America 2.266
EU - Europa 1.161
SA - Sud America 395
AF - Africa 75
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.865
Nazione #
SG - Singapore 4.226
US - Stati Uniti d'America 2.164
CN - Cina 831
IT - Italia 468
HK - Hong Kong 425
BR - Brasile 295
VN - Vietnam 188
GB - Regno Unito 171
FR - Francia 142
DE - Germania 99
IN - India 76
NL - Olanda 73
CA - Canada 45
MX - Messico 44
FI - Finlandia 37
AR - Argentina 32
ID - Indonesia 27
ZA - Sudafrica 26
ES - Italia 25
TR - Turchia 25
AT - Austria 23
BD - Bangladesh 22
JP - Giappone 22
EC - Ecuador 21
UA - Ucraina 19
AU - Australia 18
PL - Polonia 17
CO - Colombia 16
RU - Federazione Russa 15
EG - Egitto 13
PK - Pakistan 13
LT - Lituania 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
PE - Perù 10
SA - Arabia Saudita 9
TN - Tunisia 9
CL - Cile 8
PH - Filippine 8
DK - Danimarca 7
IR - Iran 7
SE - Svezia 7
UZ - Uzbekistan 7
BG - Bulgaria 6
IE - Irlanda 6
MA - Marocco 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
LB - Libano 5
MY - Malesia 5
RO - Romania 5
DZ - Algeria 4
IL - Israele 4
OM - Oman 4
EE - Estonia 3
GT - Guatemala 3
KE - Kenya 3
KZ - Kazakistan 3
TH - Thailandia 3
TL - Timor Orientale 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
ET - Etiopia 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
NC - Nuova Caledonia 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 9.854
Città #
San Jose 729
Singapore 606
Ashburn 446
Hong Kong 418
Rome 319
Dallas 263
Hefei 257
Beijing 229
Boardman 136
London 120
Lauterbourg 115
Shanghai 83
Council Bluffs 81
Ho Chi Minh City 76
Amsterdam 56
Munich 50
Los Angeles 40
Santa Clara 37
Hanoi 36
New York 26
Mexico City 24
Turku 23
São Paulo 21
Pune 18
Toronto 18
Ankara 17
Tokyo 17
San Francisco 16
Washington 16
Bari 15
Brooklyn 15
Warsaw 15
Frankfurt am Main 14
Haiphong 14
Atlanta 13
Helsinki 13
Chennai 12
Milan 12
Hangzhou 11
Johannesburg 10
Nuremberg 10
Rio de Janeiro 10
Boston 9
Changsha 9
Jinan 9
Montreal 9
Naples 9
Seattle 9
Vienna 9
Chicago 8
Guangzhou 8
Jaguariúna 8
Qingdao 8
West Jordan 8
Brasília 7
Charlotte 7
Leicester 7
Orem 7
Baghdad 6
Guayaquil 6
Las Vegas 6
Melbourne 6
Paris 6
Quito 6
Cape Town 5
Da Nang 5
Dammam 5
Dublin 5
Hải Dương 5
Manaus 5
Pisa 5
Shijiazhuang 5
Tashkent 5
Amman 4
Biên Hòa 4
Brno 4
Cairo 4
Chaozhou 4
Cotia 4
Guarulhos 4
Kongens Lyngby 4
Lahore 4
Manchester 4
New Delhi 4
Noicattaro 4
Porto Alegre 4
Prague 4
Prayagraj 4
Reston 4
Secaucus 4
Sofia 4
State College 4
Stockholm 4
Sydney 4
Thái Bình 4
Tunis 4
Xi'an 4
Andradina 3
Barranquilla 3
Bauru 3
Totale 4.774
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 220
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 220
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 220
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 216
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 206
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 204
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 194
Leptin in immuno-rheumatological diseases 190
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 190
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 188
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 172
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 166
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 164
Adult-onset Still's disease with elderly onset: results from a multicentre study 161
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 157
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 143
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 139
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 129
A longitudinal study on caring behaviors of Italian nursing students 125
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 118
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 115
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 114
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 113
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 112
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 112
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 108
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 108
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 108
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 108
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 101
Leptin in autoimmune mechanisms of systemic rheumatic diseases 101
Cannabinoids in Autoimmune and Rheumatic Diseases 100
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 89
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 87
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 84
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 83
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 81
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 79
Polypharmacy is a determinant of hospitalization in Parkinson's disease 77
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 71
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 69
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 68
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 68
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 68
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 67
Development and implementation of the AIDA International Registry for patients with Behçet's disease 64
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 64
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 62
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 61
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 61
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 60
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 59
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 59
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 58
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 57
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 56
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 56
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 56
Phase angle could be a marker of microvascular damage in systemic sclerosis 56
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 55
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 55
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 55
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 55
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 54
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 53
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 53
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 52
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 51
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 50
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 50
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 50
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 50
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 50
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 49
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 49
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 49
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 49
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 49
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 49
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 49
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 49
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 49
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 48
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 48
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 47
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 47
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 47
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 47
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 47
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 46
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 46
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 46
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 46
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 46
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 45
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 45
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 44
Metabolic syndrome is associated with better quality of sleep in the oldest old: results from the "Mugello Study" 44
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 43
Totale 8.720
Categoria #
all - tutte 52.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20264.476 490 229 479 528 232 279 1.263 311 325 340 0 0
Totale 9.989